NEW YORK, May 8 – Genomics information provider BioWisdom said Tuesday it would incorporate InPharmix’ Statistical Analysis of Text software for searching Medline data in Discovery Portfolio, an online service that searches public and proprietary data and delivers information based on customers’ targets of interest.
InPharmix’s STAT tool searches the Medline literature database of more than 10 million abstracts using a user-supplied query and then analyzes and scoring the findings.
“Medline is an incredibly useful resource, but sometimes finding the most relevant references within it can be a daunting task. InPharmix’s STAT tool helps manage this complexity,” Derek Jones, commercial director of BioWisdom, said in a statement.
Although this deal is non-financial, James Sluka, chief scientist at InPharmix of Greenwood, Ind., said he hoped that it would lead to further cooperation between his company and BioWisdom.
BioWisdom of Cambridge, UK, aggregates and aligns multidisciplinary data, information, and technology from both the public domain and from their proprietary partners. Users can view meta-data in order to help them make decisions about what data to license or purchase.